Authors:
JONES M
PHILIP T
PALMER P
VONDERMAASE H
VINKE J
ELSON P
FRANKS CR
SELBY P
Citation: M. Jones et al., THE IMPACT OF INTERLEUKIN-2 ON SURVIVAL IN RENAL-CANCER - A MULTIVARIATE-ANALYSIS, Cancer biotherapy, 8(4), 1993, pp. 275-288
Authors:
ATZPODIEN J
KIRCHNER H
DEMULDER P
BODENSTEIN H
OLIVER T
PALMER PA
FRANKS CR
POLIWODA H
Citation: J. Atzpodien et al., SUBCUTANEOUS RECOMBINANT INTERLEUKIN-2 AND ALPHA-INTERFERON IN PATIENTS WITH ADVANCED RENAL-CELL CARCINOMA - RESULTS OF A MULTICENTER PHASE-II STUDY, Cancer biotherapy, 8(4), 1993, pp. 289-300
Authors:
HANNINEN EL
FENNER M
KIRCHNER H
DECKERT M
DUENSING S
MENZEL T
POLIWODA H
ATZPODIEN J
Citation: El. Hanninen et al., LIMITED EFFICACY OF INTERFERON-ALPHA AND VINBLASTINE AS 2ND LINE BIOCHEMOTHERAPY REGIMEN IN PATIENTS WITH PROGRESSIVE METASTATIC RENAL-CELLCARCINOMA, Cancer biotherapy, 8(4), 1993, pp. 301-306
Authors:
FUJIMAKI W
ITOH K
AN T
GANO JB
ROSS MI
MANSFIELD PF
BALCH CM
AUGUSTUS LB
KARKEVITCH DD
JOHNSTON D
FIDLER IJ
KLEINERMAN ES
Citation: W. Fujimaki et al., CYTOKINE PRODUCTION AND IMMUNE CELL ACTIVATION IN MELANOMA PATIENTS TREATED WITH LIPOSOMAL MURAMYL TRIPEPTIDE (CGP-19835A LIPID), Cancer biotherapy, 8(4), 1993, pp. 307-318
Authors:
NAKAJIMA I
OZAKI M
JINNAI H
SHILAYAMA Y
HIROHATA T
OKUNO K
YASUTOMI M
Citation: I. Nakajima et al., ENHANCED ACTIVITY AGAINST SYNGENEIC MURINE TUMORS BY INTRASPLENIC INJECTION OF RECOMBINANT INTERLEUKIN-2 (IL-2) AND INTERLEUKIN-1 (IL-1), Cancer biotherapy, 8(4), 1993, pp. 319-326
Citation: J. Xiang et al., RECOMBINANT BIFUNCTIONAL MOLECULE FV IFN-GAMMA POSSESSES THE ANTITUMOR FV AS WELL AS THE GAMMA-INTERFERON ACTIVITIES/, Cancer biotherapy, 8(4), 1993, pp. 327-337
Citation: Sc. Nair et al., PROTECTIVE EFFECTS OF CROCETIN ON THE BLADDER TOXICITY INDUCED BY CYCLOPHOSPHAMIDE, Cancer biotherapy, 8(4), 1993, pp. 339-344
Citation: A. Lovqvist et al., BINDING, INTERNALIZATION AND EXCRETION OF TGF-ALPHA-DEXTRAN ASSOCIATED RADIOACTIVITY IN CULTURED HUMAN GLIOMA-CELLS, Cancer biotherapy, 8(4), 1993, pp. 345-356
Citation: H. Ohnishi et al., SUCCESSFUL IN-VIVO GENERATION OF CANINE LYMPHOKINE-ACTIVATED KILLER-CELLS BY CONTINUOUS RECOMBINANT INTERLEUKIN-2 INFUSION THROUGH THE SPLENIC ARTERY, Cancer biotherapy, 8(3), 1993, pp. 213-222
Authors:
GOMELLA LG
MCGINNIS DE
LATTIME EC
BUTLER K
BALTISH M
THOMPSON I
MARSHALL ME
Citation: Lg. Gomella et al., TREATMENT OF TRANSITIONAL-CELL CARCINOMA OF THE BLADDER WITH INTRAVESICAL INTERLEUKIN-2 - A PILOT-STUDY, Cancer biotherapy, 8(3), 1993, pp. 223-227
Authors:
MERTENS WC
BRAMWELL VHC
BANERJEE D
GWADRYSRIDHAR F
ALMUTTER N
PARHAR RS
LALA PK
Citation: Wc. Mertens et al., SUSTAINED ORAL INDOMETHACIN AND RANITIDINE WITH INTERMITTENT CONTINUOUS-INFUSION INTERLEUKIN-2 IN ADVANCED RENAL-CELL CARCINOMA, Cancer biotherapy, 8(3), 1993, pp. 229-233
Citation: L. Krishnaveni et al., CHROMOSOMAL CHANGES DURING THE ACQUISITION OF RESISTANCE TO ADRIAMYCIN IN TUMORIGENIC HUMAN SYNOVIAL-CELLS, Cancer biotherapy, 8(3), 1993, pp. 235-239
Citation: Ak. Lee et al., INCREASED OXYGEN-TENSIONS MODULATE THE CELLULAR COMPOSITION OF THE ADAPTIVE IMMUNE-SYSTEM IN BALB C MICE/, Cancer biotherapy, 8(3), 1993, pp. 241-252
Authors:
XIANG J
LIU EW
DELBAERE LTJ
CHEN ZN
LUO XM
QI YM
RATHGEBER C
Citation: J. Xiang et al., THE TYROSINE RESIDUE AT POSITION-97 IN THE V(H)-CDR3-REGION OF A MOUSE-HUMAN CHIMERIC ANTI-COLORECTAL CARCINOMA ANTIBODY CONTRIBUTES HYDROGEN-BONDING TO THE TAG72-ANTIGEN, Cancer biotherapy, 8(3), 1993, pp. 253-262
Citation: L. Li et al., PROTECTIVE EFFECT OF GYPENOSIDES AGAINST OXIDATIVE STRESS IN PHAGOCYTES, VASCULAR ENDOTHELIAL-CELLS AND LIVER-MICROSOMES, Cancer biotherapy, 8(3), 1993, pp. 263-272
Authors:
PALMER PA
ATZPODIEN J
PHILIP T
NEGRIER S
KIRCHNER H
VONDERMAASE H
GEERTSEN P
EVERS P
LORIAUX E
OSKAM R
ROEST G
VINKE J
FRANKS CR
Citation: Pa. Palmer et al., A COMPARISON OF 2 MODES OF ADMINISTRATION OF RECOMBINANT INTERLEUKIN-2 - CONTINUOUS INTRAVENOUS-INFUSION ALONE VERSUS SUBCUTANEOUS ADMINISTRATION PLUS INTERFERON-ALPHA IN PATIENTS WITH ADVANCED RENAL-CELL CARCINOMA, Cancer biotherapy, 8(2), 1993, pp. 123-136
Authors:
SMITH BW
KURZMAN ID
SCHULTZ KT
CZUPRYNSKI CJ
MACEWEN EG
Citation: Bw. Smith et al., MURAMYL PEPTIDES AUGMENT THE IN-VITRO AND IN-VIVO CYTOSTATIC ACTIVITYOF CANINE PLASTIC-ADHERENT MONONUCLEAR-CELLS AGAINST CANINE OSTEOSARCOMA CELLS, Cancer biotherapy, 8(2), 1993, pp. 137-144
Citation: A. Lindstrom et J. Carlsson, PENETRATION AND BINDING OF EPIDERMAL GROWTH FACTOR-DEXTRAN CONJUGATESIN SPHEROIDS OF HUMAN GLIOMA ORIGIN, Cancer biotherapy, 8(2), 1993, pp. 145-158
Authors:
GRIDLEY DS
SURA SS
UHM JR
LIN CH
KETTERING JD
Citation: Ds. Gridley et al., EFFECTS OF ANTI-TRANSFORMING GROWTH-FACTOR-BETA ANTIBODY AND INTERLEUKIN-2 IN TUMOR-BEARING MICE, Cancer biotherapy, 8(2), 1993, pp. 159-170